GlassScriptPhysician profile
Gregory F Grau
NPI 1922051051
$6,099.12
in general payments reported to CMS, 2019-2025
31 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $231 · 2021: $95.53 · 2022: $2,259 · 2023: $971 · 2024: $1,924 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,643 · Travel and Lodging: $1,409 · Education: $18.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,643.45 |
| Travel and Lodging | $1,409.15 |
| Education | $18.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,099.72 | 2022-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA, Regranex |
| Arthrex, INC. | $1,659.40 | 2023-2024 | |
| Depuy Synthes Sales INC. | $417.10 | 2019-2025 | Monovisc, Va-Lcp, Orthovisc |
| Legacy Ortho LLC | $243.33 | 2024 | |
| Stryker Corporation | $221.28 | 2021-2024 | Adapt, Knotilus Anchor, 3.5mm, Reunion |
| Kowa Pharmaceuticals America, INC. | $194.99 | 2022-2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $167.79 | 2022-2025 | Zilretta, Iovera, Exparel |
| Nevro Corp. | $148.62 | 2024 | Senza |
| Pacira Therapeutics, INC. | $133.14 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $124.21 | 2019-2023 | Euflexxa |
| Sanofi-Aventis U.S. LLC | $73.92 | 2019-2023 | |
| Ethicon US, LLC | $69.98 | 2023-2024 | Surgicel Nu-Knit, Stratafix, Ethicon |
| Orthofix Medical, INC. | $61.18 | 2021-2025 | Physio-Stim |
| Radius Health, INC. | $60.82 | 2019-2024 | Tymlos |
| Wright Medical Technology, INC. | $42.91 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $36.76 | 2024 | Zynrelef |
| Assertio Therapeutics, INC. | $34.66 | 2020 | |
| Acumed LLC | $32.82 | 2023 | Acumed |
| Fx Shoulder Solutions, INC | $29.74 | 2019 | |
| Convatec INC. | $29.28 | 2023 | |
| Abbvie INC. | $24.40 | 2022 | |
| Medartis INC. | $24.35 | 2024 | Aptus |
| Horizon Therapeutics Plc | $22.82 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.77 | 2020 | |
| Fidia Pharma USA INC. | $20.18 | 2023 | Hymovis |
| Kci USA, INC. | $18.88 | 2023 | V.A.C. Veraflo, Prevena |
| Bioventus LLC | $18.66 | 2019 | |
| Djo, LLC | $18.65 | 2019 | |
| Amgen INC. | $17.68 | 2024 | Evenity, Prolia |
| Zimmer Biomet Holdings, INC. | $15.66 | 2023 | A.L.P.S., Tricera Handpiece, Accufill |
| Osiris Therapeutics INC. | $13.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Grau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.